0.00Open0.15Pre Close0 Volume10 Open Interest69.00Strike Price0.00Turnover399.71%IV13.97%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.0480Delta0.0137Gamma533.55Leverage Ratio-1.8346Theta0.0000Rho-25.59Eff Leverage0.0018Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet